ARS Pharmaceuticals, Inc. - 10-Q Filing
ARS Pharmaceuticals reports Q3 2025 financial results highlighting customer concentration risks and ongoing collaboration agreements.
Tickers: $SPRY
More Regulatory news
- LiveOne, Inc. - 8-K Filing
- Solana Co - 10-Q Filing
- Solana Co - 8-K Filing
- DeFi Development Corp. - 8-K Filing
- Stablecoin Development Corp - 8-K Filing
- BCP Investment Corp - 8-K Filing
- OneWater Marine Inc. - 8-K Filing
- Moleculin Biotech, Inc. - 8-K Filing
- Investcorp Credit Management BDC, Inc. - 8-K Filing
- Presurance Holdings, Inc. - 10-Q Filing